These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 39105870)

  • 21. Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.
    Hoesli R; Birkeland AC; Rosko AJ; Issa M; Chow KL; Michmerhuizen NL; Mann JE; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; McHugh JB; Brenner JC; Spector ME
    Oral Oncol; 2018 Feb; 77():83-89. PubMed ID: 29362129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.
    Sanchez-Canteli M; Granda-Díaz R; Del Rio-Ibisate N; Allonca E; López-Alvarez F; Agorreta J; Garmendia I; Montuenga LM; García-Pedrero JM; Rodrigo JP
    Cancer Immunol Immunother; 2020 Oct; 69(10):2089-2100. PubMed ID: 32448984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
    Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
    Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
    Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
    Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I conventional dendritic cells and CD8
    Kirchner J; Plesca I; Rothe R; Resag A; Löck S; Benešová I; Rupp L; Linge A; Wehner R; Krause M; Schmitz M
    Front Immunol; 2024; 15():1414298. PubMed ID: 38938577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
    Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC
    BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
    de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
    Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma-Potential Biomarkers for Targeted Therapy Concepts.
    Wuerdemann N; Pütz K; Eckel H; Jain R; Wittekindt C; Huebbers CU; Sharma SJ; Langer C; Gattenlöhner S; Büttner R; Speel EJ; Suchan M; Wagner S; Quaas A; Klussmann JP
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanylate binding protein 5 is an immune-related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis.
    Hasegawa M; Amano Y; Kihara A; Matsubara D; Fukushima N; Takahashi H; Chikamatsu K; Nishino H; Mori Y; Yoshida N; Niki T
    Cancer Med; 2024 Jul; 13(13):e7431. PubMed ID: 38978333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
    Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
    J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer.
    Kotwal A; Vance K; Hajric K; Yuil-Valdes A; Swanson B; Martinez Duarte E; Shats O; Hollingsworth M; Band H; Goldner W
    Thyroid; 2024 Aug; 34(8):999-1006. PubMed ID: 38916182
    [No Abstract]   [Full Text] [Related]  

  • 33. Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma.
    Long L; Zhang L; Yang Y; Zhou Y; Chen H
    Immunotherapy; 2022 Apr; 14(6):419-431. PubMed ID: 35187955
    [No Abstract]   [Full Text] [Related]  

  • 34. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
    Wang J; Tian S; Sun J; Zhang J; Lin L; Hu C
    BMC Cancer; 2020 Aug; 20(1):731. PubMed ID: 32758195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the tumor immune microenvironment and tumor-infiltrating lymphocyte subgroups on laryngeal cancer prognosis.
    Tevetoğlu F; Çomunoğlu N; Yener HM
    Sci Prog; 2024; 107(3):368504241266087. PubMed ID: 39044316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma.
    Sun W; Wei FQ; Li WJ; Wei JW; Zhong H; Wen YH; Lei WB; Chen L; Li H; Lin HQ; Iqbal M; Wen WP
    Br J Cancer; 2017 Nov; 117(11):1631-1643. PubMed ID: 28949956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC.
    Yang Z; Tian H; Bie F; Xu J; Zhou Z; Yang J; Li R; Peng Y; Bai G; Tian Y; Chen Y; Liu L; Fan T; Xiao C; Zheng Y; Zheng B; Wang J; Li C; Gao S; He J
    Front Immunol; 2021; 12():788985. PubMed ID: 34992605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ analysis of CCR8
    Hayashi Y; Ueyama A; Funaki S; Jinushi K; Higuchi N; Morihara H; Hirata M; Nagira Y; Saito T; Kawashima A; Iwahori K; Shintani Y; Wada H
    BMC Cancer; 2024 May; 24(1):627. PubMed ID: 38783281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma.
    Zhong R; Zhan J; Zhang S
    Appl Biochem Biotechnol; 2024 Jul; 196(7):3891-3913. PubMed ID: 37792175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.